Back to Market返回行情

LFMD LifeMD, Inc.

USHealthcare
$4.70+0.11%OpenMarket Cap: $227.1M

As of 2026-07-09 14:52

Why LFMD matters now

LifeMD, Inc. (LFMD) is a US stock in Healthcare. The latest InvestLog snapshot shows $4.70 with +0.11% on the session and $227.1M in market capitalization; recent performance reads 1-month +10.47% and YTD +39.30%.

The latest financial table shown here is Q1 2026, with revenue of $50.2M, net income of $-8.9M, and EPS of $-0.20. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield 6.5%.

The latest indexable market news headline is "LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock" from GlobeNewsWire.

Additional event context on this page matters because analyst consensus is Buy with a median target of $10.00; recent insider activity includes Sripad Umesh filing . These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

PEG

P/B

14.95

P/S

1.05

EV/EBITDA

-47.76

DCF Value

$-18.84

FCF Yield

6.5%

Div Yield

0.0%

Margins & Returns

Gross Margin

85.9%

Operating Margin

-5.9%

Net Margin

-7.4%

ROE

-172.3%

ROA

-23.2%

ROIC

-60.8%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$50.2M$-8.9M$-0.20
Q4 2025$46.9M$-1.5M$-0.05
FY 2025$194.1M$-7.1M$-0.23
Q3 2025$60.2M$-3.8M$-0.10

Analyst Ratings

Consensus

Buy

Target (Consensus)

$10.00

Target (Median)

$10.00

Target Range

$10.00 - $10.00

Strong Buy: 0Buy: 8Hold: 0Sell: 0Strong Sell: 0
HC Wainwright & Co.Buy
2026-05-26
BTIGBuy
2026-05-04
MizuhoOutperform
2026-03-16
Freedom BrokerBuy
2026-03-12
Freedom Capital MarketsBuy
2026-03-12

Trading Activity

Insider Trades

Sripad Umesh
Sell2026-06-03
Sripad Umeshofficer: Chief Technology Officer
Sell2026-06-03
Kavthekar Atulofficer: Chief Financial Officer
Sell2026-05-13
Pisano Christopher Aofficer: Chief Marketing Officer
Sell2026-04-01
Kavthekar Atul
Sell2026-04-01

Company Info

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Country

US

Exchange

Beta

1.99

LifeMD, Inc. operates as a leading digital health company, specializing in direct-to-consumer telemedicine across the United States. The firm links individuals with licensed medical professionals to address a diverse spectrum of health concerns, including concierge services, men's sexual health, dermatological conditions, and more. Under its umbrella, LifeMD manages several specialized virtual care platforms: ShapiroMD is a telehealth brand focused on hair restoration, delivering virtual consultations, prescription medications, patented over-the-counter formulations, an FDA-cleared medical device, and custom-compounded topical treatments for both male and female hair loss. RexMD serves as a men's telehealth brand, providing virtual medical treatment from licensed providers for a wide array of male-specific health needs. LifeMD Primary Care offers a personalized, subscription-based virtual primary care solution, addressing routine, urgent, and chronic health management requirements. This mobile-centric platform integrates remote consultations, medication management, diagnostic services, and imaging referrals. Cleared is a telehealth service dedicated to offering personalized therapies for allergic, asthmatic, and immunological conditions. Nava MD stands as a skincare and tele-dermatology brand catering specifically to women, facilitating virtual access to dermatologists and other specialists for medical treatment. Additionally, the company provides PDFSimpli, a cloud-based software-as-a-service (SaaS) platform that empowers users to create, edit, convert, sign, and share PDF documents online. LifeMD distributes its offerings directly to individuals, via its own e-commerce channels, and through collaborations with external partners. Originally established in 1994 as Conversion Labs, Inc., the company rebranded to LifeMD, Inc. in February 2021 and is headquartered in New York City.